Effect of prostaglandin E 1  administration on the liver glycogen synthetase and phosphorylase systems.
D000311:Adrenal Glands / Q000378:metabolism / Q000502:physiology; D000315:Adrenalectomy; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000824:Animal Nutritional Physiological Phenomena; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism; D005215:Fasting; D005964:Glucosyltransferases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D006003:Glycogen; D000882:Haplorhini; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008112:Liver Glycogen / Q000378:metabolism; D008297:Male; D010425:Pentolinium Tartrate / Q000494:pharmacology; D006005:Phosphorylases / Q000037:antagonists & inhibitors / Q000378:metabolism; D011433:Propranolol / Q000494:pharmacology; D011453:Prostaglandins / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D002395:Catecholamines; D008112:Liver Glycogen; D011453:Prostaglandins; D006003:Glycogen; D010425:Pentolinium Tartrate; D011433:Propranolol; D005964:Glucosyltransferases; D006005:Phosphorylases